1. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
- Author
-
Huen SC, Hall I, Topal J, Mahnensmith RL, Brewster UC, and Abu-Alfa AK
- Abstract
Peritoneal dialysis-associated peritonitis from such resistant organisms as vancomycin-resistant enterococci increasingly is occurring and is challenging to treat. We describe 2 cases of vancomycin-resistant entercoccus peritonitis successfully treated with intraperitoneal daptomycin. Both patients were on automated peritoneal dialysis therapy with culture-positive vancomycin-resistant Enterococcus faecium peritonitis and were treated with 10 to 14 days of intraperitoneal daptomycin given every 4 hours through manual peritoneal dialysate exchanges. Despite the known degradation in dextrose solutions, intraperitoneal daptomycin was effective in clearing both infections. Neither patient experienced a relapse or repeated peritonitis. Additional studies of dosing and pharmacokinetics of intraperitoneal daptomycin in the treatment of patients with vancomycin-resistant enterococcus peritonitis are needed. Copyright © 2009 National Kidney Foundation, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF